Since the coronavirus outbreak in China, the China National Medical Product Administration (NMPA) and its provincial affiliates have initiated the emergency approval process for medical devices and IVDs in order to solve the shortage of medical supplies on the market.
The whole approval process can be done as short as two weeks.
So far, four 2019-nCoV Assays are approved for clinical use by the NMPA. At the province level, new products like face masks, respirators, protection overalls, protection glasses from manufacturers are registered and ready to bulk production.
If any manufacturers produce the products with an shortage in China for coronavirus emergency, please feel free to contact us via firstname.lastname@example.org for product registration.